Matthews Judith M.

Chief Financial Officer at Iterum Therapeutics plc

Sold, on record
$169k
Dollars the filings state
Form 4 sales
3
Latest Mar 14, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Iterum Therapeutics plcUnusual
    Sep 30, 2020 2020

    Sold 56,130 shares at $1.64 ($92k)

    Matthews Judith M., Chief Financial Officer

    Sold 100% of holdings ($92k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Iterum Therapeutics plcUnusual
    Jan 26, 2021 +118 days

    Sold 33,868 shares at $1.73 ($59k)

    Matthews Judith M., Chief Financial Officer

    Sold 54.2% of holdings ($108k position)28,632 shares leftFiling

  3. 3 Form 4 sale Iterum Therapeutics plcUnusual
    Mar 14, 2022 +412 days

    Sold 47,132 shares at $0.38 ($18k)

    Matthews Judith M., Chief Financial Officer

    Sold 36.6% of holdings ($49k position)81,500 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Matthews Judith M.
Source
Mar 14, 2022Mar 15, 2022Iterum Therapeutics plcChief Financial OfficerForm 4 sale47,132$18k36.6%UnusualSEC
Jan 26, 2021Jan 27, 2021Iterum Therapeutics plcChief Financial OfficerForm 4 sale33,868$59k54.2%UnusualSEC
Sep 30, 2020Oct 2, 2020Iterum Therapeutics plcChief Financial OfficerForm 4 sale56,130$92k100.0%UnusualSEC